XML 95 R75.htm IDEA: XBRL DOCUMENT v3.23.3
Business Combinations (Details)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Oct. 08, 2023
shares
Aug. 10, 2023
USD ($)
D
$ / shares
shares
Sep. 30, 2023
USD ($)
shares
Sep. 30, 2023
USD ($)
shares
Sep. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
shares
Dec. 31, 2021
shares
Reverse Recapitalization [Line Items]              
Exchange ratio | shares   0.02471853          
Stock converted, reverse recapitalization (in shares) | shares   21,999,886          
Proceeds from transaction   $ 42,854          
Proceeds from MTAC trust account   2,704          
Proceeds from private placement   40,150          
Expenses related to business combination   1,742   $ 1,116 $ 0    
Proceeds from business combination   36,854   $ 36,854 $ 0    
Transaction costs incurred   6,069          
Transaction costs paid from proceeds   4,327          
MTAC warrants   $ 28,927          
Common stock, shares outstanding (in shares) | shares   26,316,681 26,316,681 26,316,681   347,926 264,977
Options and RSU's outstanding (in shares) | shares   2,816,224 7,500,732 7,500,732      
Warrants outstanding (in shares) | shares   14,266,605 14,266,605 14,266,605   2,871,084  
Sale of stock (in shares) | shares   4,015,002          
Sale of stock, price per share (in dollars per share) | $ / shares   $ 10.00          
Net proceeds on sale of stock   $ 40,150          
Derivative instrument, contingent consideration, liability, earnout period 5 years 5 years          
Warrant liability              
Reverse Recapitalization [Line Items]              
MTAC warrants     $ 5,421 $ 5,421   $ 369  
Minimum              
Reverse Recapitalization [Line Items]              
Earnout period, threshold trading days | D   20          
Maximum              
Reverse Recapitalization [Line Items]              
Earnout period, threshold consecutive trading days | D   30          
Tranche One              
Reverse Recapitalization [Line Items]              
Earnout shares vesting percentage   25          
Earnout shares vesting requirement, weighted average price per share (in dollars per share) | $ / shares   $ 15.00          
Tranche Two              
Reverse Recapitalization [Line Items]              
Earnout shares vesting percentage   25          
Earnout shares vesting requirement, weighted average price per share (in dollars per share) | $ / shares   $ 20.00          
Tranche Three              
Reverse Recapitalization [Line Items]              
Earnout shares vesting percentage   25          
Earnout shares vesting requirement, weighted average price per share (in dollars per share) | $ / shares   $ 25.00          
Tranche Four              
Reverse Recapitalization [Line Items]              
Earnout shares vesting percentage   25          
Earnout shares vesting requirement, weighted average price per share (in dollars per share) | $ / shares   $ 30.00          
MedTech Acquisition Corporation              
Reverse Recapitalization [Line Items]              
Expenses related to business combination   $ 6,000          
MTAC Warrants              
Reverse Recapitalization [Line Items]              
MTAC warrants   $ 2,568          
Loss on change in fair value     $ 2,853        
Gain on change in fair value       $ 660      
Contingent earnout liability              
Reverse Recapitalization [Line Items]              
Shares unvested (in shares) | shares 3,125,000 3,125,000